212 related articles for article (PubMed ID: 30770534)
1. A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
Han A; Czajkowski LM; Donaldson A; Baus HA; Reed SM; Athota RS; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
Clin Infect Dis; 2019 Nov; 69(12):2082-2090. PubMed ID: 30770534
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK
mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330
[TBL] [Abstract][Full Text] [Related]
3. Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.
Memoli MJ; Czajkowski L; Reed S; Athota R; Bristol T; Proudfoot K; Fargis S; Stein M; Dunfee RL; Shaw PA; Davey RT; Taubenberger JK
Clin Infect Dis; 2015 Mar; 60(5):693-702. PubMed ID: 25416753
[TBL] [Abstract][Full Text] [Related]
4. Assessment of CD8
Evans TG; Castellino F; Kowalik Dobczyk M; Tucker G; Walley AM; Van Leuven K; Klein J; Rutkowski K; Ellis C; Eagling-Vose E; Treanor J; van Baalen C; Filkov E; Laurent C; Thacker J; Asher J; Donabedian A
Lancet Microbe; 2024 Jul; 5(7):645-654. PubMed ID: 38729196
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
mBio; 2018 Jan; 9(1):. PubMed ID: 29362240
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
7. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
8. Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
Fullen DJ; Noulin N; Catchpole A; Fathi H; Murray EJ; Mann A; Eze K; Balaratnam G; Borley DW; Gilbert A; Lambkin-Williams R
PLoS One; 2016; 11(1):e0145902. PubMed ID: 26761707
[TBL] [Abstract][Full Text] [Related]
9. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
[TBL] [Abstract][Full Text] [Related]
11. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
[TBL] [Abstract][Full Text] [Related]
12. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.
Watson JM; Francis JN; Mesens S; Faiman GA; Makin J; Patriarca P; Treanor JJ; Georges B; Bunce CJ
Virol J; 2015 Feb; 12():13. PubMed ID: 25645025
[TBL] [Abstract][Full Text] [Related]
14. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
[TBL] [Abstract][Full Text] [Related]
15. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Mallory RM; Yi T; Ambrose CS
Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
[TBL] [Abstract][Full Text] [Related]
17. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
Houser KV; Pearce MB; Katz JM; Tumpey TM
J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
[TBL] [Abstract][Full Text] [Related]
18. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
[TBL] [Abstract][Full Text] [Related]
20. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
